Yurogen Biosystems Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
23
- Latest Deal Type
-
M&A
Yurogen Biosystems General Information
Description
Developer of monoclonal antibody technology intended for scientific research and drug development. The company offers rabbit monoclonal antibodies, llama monoclonal antibodies, human monoclonal antibodies, flow cytometry analysis, cell sorting services, and bioanalytical services, enabling biotechnology and pharmaceutical firms to discover and engineer customized antibodies for diagnostics and therapeutic applications.
Contact Information
Website
www.yurogen.com(Operating Subsidiary)
Corporate Office
- 1 Innovation Drive
- Worcester, MA 01605
- United States
Corporate Office
- 1 Innovation Drive
- Worcester, MA 01605
- United States
Yurogen Biosystems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 05-Mar-2021 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Startup |
Yurogen Biosystems Comparisons
Industry
Financing
Details
Yurogen Biosystems Competitors (16)
One of Yurogen Biosystems’s 16 competitors is Absolute Antibody, a Private Equity-Backed company based in Redcar, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Absolute Antibody | Private Equity-Backed | Redcar, United Kingdom | ||||
| Integrated DNA Technologies | Formerly PE-Backed | Coralville, IA | ||||
| Personal Genome Diagnostics | Formerly VC-backed | Baltimore, MD | ||||
| DJS Antibodies | Formerly VC-backed | Bicester, United Kingdom | ||||
| Creative Diagnostics | Corporation | Shirley, NY |
Yurogen Biosystems Patents
Yurogen Biosystems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250171542-A1 | Anti-programmed death-ligand 1 (pd-l1) antibodies | Pending | 28-Feb-2022 | ||
| US-20220056112-A1 | Monoclonal antibodies against sars-cov-2 nucleocapsid protein and uses thereof | Inactive | 11-Aug-2020 | ||
| US-20220056111-A1 | Monoclonal antibody against spike s1 protein of sars-cov-2 and use thereofof | Inactive | 11-Aug-2020 | ||
| US-20200386770-A1 | Monoclonal antibodies against human pd-l1 and uses thereof | Inactive | 04-Jun-2019 | G01N33/5758 |
Yurogen Biosystems Signals
Yurogen Biosystems Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Massachusetts Biomedical Initiatives | Accelerator/Incubator |
Yurogen Biosystems FAQs
-
When was Yurogen Biosystems founded?
Yurogen Biosystems was founded in 2015.
-
Where is Yurogen Biosystems headquartered?
Yurogen Biosystems is headquartered in Worcester, MA.
-
What is the size of Yurogen Biosystems?
Yurogen Biosystems has 23 total employees.
-
What industry is Yurogen Biosystems in?
Yurogen Biosystems’s primary industry is Biotechnology.
-
Is Yurogen Biosystems a private or public company?
Yurogen Biosystems is a Private company.
-
What is Yurogen Biosystems’s current revenue?
The current revenue for Yurogen Biosystems is .
-
Who are Yurogen Biosystems’s investors?
Massachusetts Biomedical Initiatives has invested in Yurogen Biosystems.
-
Who are Yurogen Biosystems’s competitors?
Absolute Antibody, Integrated DNA Technologies, Personal Genome Diagnostics, DJS Antibodies, and Creative Diagnostics are some of the 16 competitors of Yurogen Biosystems.
-
When was Yurogen Biosystems acquired?
Yurogen Biosystems was acquired on 05-Mar-2021.
-
Who acquired Yurogen Biosystems?
Yurogen Biosystems was acquired by ABclonal Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process